Andrew Picca

Andrew Picca

Auto-generated profile, based on publicly available information

Andrew Picca


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2023 in Academic Pediatrics
Verified
Journal Article
Closed access
SRSuzanne Reed
Suzanne Reed
APAndrew Picca
Andrew Picca
LLLaura Lockwood
Laura Lockwood
LTLynn Thoreson
Lynn Thoreson
ABAnn E. Burke
Ann E. Burke
KGKimberly A. Gifford
Kimberly A. Gifford

23 August 2023 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
APAndrew Picca
Andrew Picca
SRSuzanne Reed
Suzanne Reed

20 August 2019 in Clinical Pediatrics
Verified
Journal Article
Closed access
PDF file
APAndrew Picca
Andrew Picca
MRMason Ruthford
Mason Ruthford
MGMajd T. Ghanim
Majd T. Ghanim
MSMorgan Sims
Morgan Sims
JKJulie Kanter
Julie Kanter

1 January 2025 in Advances in Hematology
Verified
Journal Article
Open access
APAndrew Picca
Andrew Picca
DKDavid Kling
David Kling
AJAmanda Jacobson-Kelly
Amanda Jacobson-Kelly
KNKathleen Nicol
Kathleen Nicol
JSJoseph Stanek
Joseph Stanek
VRVilmarie Rodriguez
Vilmarie Rodriguez
Background: Iron deficiency anemia (IDA) is the most common form of pediatric anemia, with first‐line treatment focusing on iron repletion through oral and/or intravenous iron. The American Society of Hematology (ASH)/the American Society of Pediatric Hematology and Oncology (ASPHO) Choosing Wisely Campaign recommends against packed red blood cell (PRBC) transfusion for asymptomatic IDA. PRBCs are a finite resource and carry treatment associated risk compared to iron therapies. The use of oral and intravenous iron is an effective, tolerated therapy modality for IDA which can be overlooked based on the degree of anemia. Study Design and Methods: Plan, Do, Study, Act methodology was used for this single institution quality improvement initiative. The objective was to decrease the percentage of PRBC transfusions in all admitted IDA patients from a baseline of 72% to a target of 50% by December 2022 and to sustain for 12 months. Interventions consisted of multidisciplinary, evidence‐based didactic education sessions and development of a single institution clinical practice guideline for the treatment of IDA. Results: In the pre‐education/baseline group, 72% ( n = 57/79) of patients received PRBC transfusion for the treatment of IDA, compared to the posteducation/intervention group where 38% ( n = 29/76) of patients received PRBC transfusion for the treatment of IDA ( p value < 0.0001). In the pre‐education/baseline group, 19% ( n = 11/57) of patients received PRBC transfusions not indicated based on the developed CPG, compared to 6.9% ( n = 2/18) in the posteducation/intervention group ( p value = 0.20). Discussion: This work demonstrates how multidisciplinary, education‐ and evidence‐based interventions lead to clinically and statistically significant reductions in PRBC transfusion for admitted patients with IDA.

5 August 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
CAChristina Abrams
Christina Abrams
DWDeAsia Witherspoon
DeAsia Witherspoon
EKEverette Keller
Everette Keller
APAndrew J. Picca
Andrew J. Picca
MBMaria Boucher
Maria Boucher
Background: Quality care of individuals with sickle cell disease (SCD) is dependent upon education of the providers on their care team. Previous studies demonstrate lack of resident and provider comfort regarding care of patients with SCD, yet none have assessed these in medical students. Objective: This study aims to evaluate the adequacy of the research instrument for measuring medical students’ knowledge, confidence, and comfort regarding SCD and related complications prior to wider distribution. Methods: A self-assessment survey was distributed to medical students at two universities to evaluate their knowledge, confidence, and comfort in general SCD topics, in all clinical settings, and regarding common complications. Results: Of the 98 responses, knowledge (p < 0.001) and confidence (p = 0.02) were significantly different between topics, including epidemiology and genetics, pathophysiology, and treatment options. For “treatment options”, there were significant differences in knowledge (p = 0.02) and confidence (p = 0.02) between medical students at different levels of training. Students felt least knowledgeable and least comfortable with care of pregnant women and most knowledgeable and most comfortable with acute pain management. Caring for patients with specific SCD-related conditions increased knowledge and comfort across all domains. Conclusions: This instrument was adequate for measuring knowledge, confidence, and comfort in caring for those with SCD across all clinical settings. We identified a lack of knowledge, confidence, and comfort regarding treatment for those with SCD starting early in medical careers, which improves after caring for patients with various complications. Thus, educating and providing SCD patient experiences is crucial for medical student management confidence related to SCD.